Alzheimer's Drug Donanemab

An experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration advisory panel. The drug is designed to treat symptoms of early Alzheimer’s disease and has shown promising results in clinical trials.

Misinterpretation of Biden's Reference to mRNA Cancer Vaccines

President Joe Biden's reference to mRNA cancer vaccines during his State of the Union address was misinterpreted on social media, leading to false claims that COVID-19 vaccines are being used to cure cancer. In reality, mRNA technology used in COVID-19 vaccines is being studied to treat cancer, with promising results in clinical trials for different types of cancers.

New Male Contraceptive Method

Researchers at the Salk Institute have developed a promising new method for male contraception that is safe, effective, and reversible. The method targets a specific protein complex involved in sperm production without impacting other aspects of reproductive health. Clinical trials are still needed before it reaches the market.